OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
(Q39866378)
scientific article published on June 2010
scientific article published on June 2010
Language:
Current Data About
OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
other details
description | scientific article published on June 2010 |
External Links
(P356) |
10.2217/FON.10.66
|
(P698) |
20528232
|